Uncategorized
As diaries fill with flights, train journeys and overnight stays, it’s common for patients on weekly GLP-1 therapy to worry that travel will break their rhythm. The good news is that most trips, from a weekend city break to a long-haul family holiday, can be managed safely with a little preparation. This article is written […]
Every year as the festive season approaches, weight‑management clinics see the same pattern: routines loosen, social calendars fill, food environment cues multiply, and large meals come thick and fast. That doesn’t make December an “off‑limits” month for treatment—if anything, it’s the time when skilled counselling and clear safety messages become most valuable. With thoughtful preparation […]
Obesity is one of the UK’s most urgent health challenges. Around two-thirds of adults in England are overweight or obese (NHS Digital) — and the pressures on health services are mounting. In 2025, weight management pathways are evolving fast. With updated NICE guidance, growing demand for safe pharmacological interventions, and the expansion of digital-first healthcare […]
A New Era for the NHSIn September 2025, the UK government confirmed plans to launch a fully digital “NHS Online Hospital” in 2027. Patients referred by GPs will be able to access specialist consultations by video or phone rather than face-to-face in hospital settings (The Guardian: https://www.theguardian.com/politics/2025/sep/30/keir-starmer-to-announce-nhs-online-hospital-to-help-cut-waiting-lists?utm_source=chatgpt.com). The goal is to reduce waiting times, increase access […]
Digital-first healthcare is no longer a distant idea — it is the reality shaping the UK system today. From the upcoming launch of the NHS Online Hospital in 2027 (The Guardian) to increasing use of virtual consultations, artificial intelligence, and patient-facing apps, healthcare is being reshaped at speed. While technology provides exciting opportunities, it also […]
Weight management has always been one of healthcare’s greatest challenges. In the UK today, two-thirds of adults are overweight or obese (NHS Digital: https://digital.nhs.uk/data-and-information/publications/statistical/statistics-on-obesity-physical-activity-and-diet), and the demand for effective interventions has never been higher. For practitioners, understanding the history of weight loss options is more than interesting background — it’s essential. It helps frame where we […]
The growing use of GLP-1 receptor agonists in weight management has transformed how healthcare and wellbeing practitioners approach obesity treatment. However, with this transformation comes the need for specialist knowledge and training to ensure these medications are prescribed, managed, and monitored safely. What Are GLP-1 Receptor Agonists? GLP-1 (glucagon-like peptide-1) receptor agonists are a class […]
The delivery of safe, effective weight loss treatments is one of the most important responsibilities for modern healthcare and health & wellbeing practitioners. With the rise of evidence-based medical weight management, the role of practitioners has expanded beyond traditional lifestyle advice, requiring specialist knowledge, up-to-date training, and a commitment to patient safety. Why Practitioner Involvement […]
Introduction In recent years, GLP-1 receptor agonists such as Wegovy (semaglutide) and Mounjaro (tirzepatide) have reshaped conversations about weight management. Both have been hailed as breakthrough therapies, offering significant benefits for patients struggling with obesity and type 2 diabetes. Yet despite their promise, access in the UK remains uneven. Supply shortages, strict prescribing criteria, and […]
The demand for effective, evidence-based weight management is growing rapidly, and GLP-1 medications are revolutionising this space. But with new opportunities come serious responsibilities. At MJ Clinical, we empower healthcare professionals to offer GLP-1 weight-management services safely, ethically, and profitably through our CPD-accredited training programme. Why GLP-1 Weight Management Is Reshaping Clinical Practice GLP-1 receptor […]